PREPARATION AND CHARACTERIZATION OF FAST DISNTEGRATING TABLETS OF HYDRALAZINE HYDROCHLORIDE USING DESIGN OF EXPERIMENT TECHNIQUE
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2014, Vol 3, Issue 1
Abstract
Since the dose accuracy and patient’s compliance are important prerequisites for a long term treatment, there is a demand to develop a dosage form which can overcome difficulty in swallowing, inconvenience in administration while travelling, and increase patient’s acceptability. The present work was undertaken to develop fast disintegrating tablet of Hydralazine hydrochloride which will offer desired characteristics and intended benefits in hypertension. A 32 full-factorial experimental design was constructed to study the effect of type and concentration of superdisintegrant on disintegration time, wetting time and dispersion time. The tablets were prepared by direct compression technique. The ANOVA results confirmed that the studied response variables were strongly dependen on chosen factors (p<0.05). More than 90% of drug from optimized tablet was released within 5 minutes during in-vitro dissolution studies. The short term accelerated stability studies of selected formulation indicated that there was insignificant change in the drug content and percent drug released (p<0.05). It was concluded that FDT of hydralazine hydrochloride were formulated successfully.
Authors and Affiliations
Kaur, R. | Pharmaceutics division, Chandigarh College of Pharmacy, Landran, Mohali, India, Sharma, G. | Pharmaceutics division, Chandigarh College of Pharmacy, Landran, Mohali, India, Nagpal, M. | Pharmaceutics division, Chandigarh College of Pharmacy, Landran, Mohali, India, Sidhu, S. | Pharmaceutics division, Chandigarh College of Pharmacy, Landran, Mohali, India, Jain, U. K. | Chandigarh College of Pharmacy, Landran, Mohali, India, Sharma, M. *| Pharmaceutics division, Chandigarh College of Pharmacy, Landran, Mohali, India
TO STUDY SUSPECTED ADVERSE REACTIONS INCLUDING BIRTH DEFECTS IN PRIVATE APEX HEALTH CARE CENTRE (UTTAR PRADESH) INDIA.
According to the World Health Organization definition, this is any noxious, unintended, and undesired effect of a drug, which occurs at doses used in humans for prophylaxis, diagnosis, or therapy. This definition exclude...
HAEMOGLOBIN F LEVEL AND HAEMATOLOGICAL FEATURE AMONG SUDANESE CHILDREN WITH SICKLE CELL ANAEMIA UNDERGOING HYDROXYUREA THERAPY
Sickle cell anemia (SCA) is one of the major types of anemia found in Sudan.The aim of this study is to evaluate the effect of Hydroxyurea (HU) treatment on Hb F level, reticulocyte count and the haematological feature a...
Pharmacognostic Standardization and HPTLC Analysis of the Roots of Aerva ambigua/Aerva leucura
Morphoanatomy of the roots of Aerva leucura plant has been studied with the aim to aid pharmacognostic, phytochemical analysis by using WHO recommended physico-chemical determinations and authentic phytochemical procedur...
CLINICO-MICROBIOLOGICAL PROFILE OF COMMUNITY ACQUIRED PNEUMONIA IN A TERTIARY CARE HOSPITAL
Community Acquired Pneumonia (CAP) is a frequently encountered lower respiratory tract parenchymal lung infection which continues to be a major health problem leading to significant morbidity and mortality worldwide. Eti...
NAD (P) H: QUINONE OXIDOREDUCTASE 1(NQO1) POLYMORPHISMIN SUDANESE PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA
Primary or essential thrombocythaemia (ET) is a clonal haemopoietic disorder, it is one of myeloproliferative neoplasm (MPN)that manifests primarily as a marked increase in platelets count with spontaneous aggregation of...